Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets. In the historic dot.com year 2000, he trained as a CEFA analyst in Frankfurt and has since then accompanied over 20 IPOs in Germany.
Until 2018, he held various positions at banks as an asset manager, capital market and macro expert as well as fundamental equity analyst. He is passionate about the energy, commodity and technology markets as well as the tactical and strategic asset allocation of liquid investment products. As an expert speaker at investment committee meetings of funds as well as at customer events, he can still describe the course of the 1987 crash, one of the major buying opportunities of the last 33 years on the stock market.
Today, he knows that the profit in shares is not necessarily the result of buying cheaply, but above all of avoiding mistakes and recognizing in good time when markets are ready to let air out. After all, in addition to basic fundamental analysis, investing in stocks is above all a phenomenon of global liquidity and this must be monitored regularly.
Commented by André Will-Laudien
Commented by André Will-Laudien on April 22nd, 2025 | 07:20 CEST
This is the post-Easter opportunity! Evotec, Bayer, BioNTech, and Defence Therapeutics in focus
Donald Trump snubs his international partners, insults prominent Americans, and withdraws long-standing funding commitments to Harvard. Who would have thought? The new US administration is turning out to be an unpredictable fragmentation bomb that could hit anyone. Economic policy resembles a game of hot and cold when stability is needed. On the stock market, investors are trying to price in old tariffs, no tariffs, and new tariffs - every day brings a fresh bouquet of announced measures. There has hardly been a similarly volatile period in recent years, but Donald Trump is not interested in stock market prices. For the overvalued high-tech sector, this is a welcome opportunity to take profits. The biotech sector could finally take off were it not for the sharp rise in interest rates. The only thing that can help now is a case-by-case assessment of investment opportunities.
Read
Commented by André Will-Laudien on April 16th, 2025 | 07:55 CEST
Gold in focus, Defense accelerates again – Agnico Eagle, Golden Cariboo, Hensoldt, and RENK in focus
The daily theatrics are hard to beat. US President Donald Trump is engaging in slapstick and snubbing long-standing trading partners. In his own country, he leaves no stone unturned in his efforts to counterbalance the nearly USD 36 trillion national debt through savings and additional revenues. This creates great uncertainty in the stock markets and causes economic institutes to calculate more precisely whether, instead of growth, a recession may be looming. But perhaps it is all just a test to force political partners to the table. However, the threat of inflation means that precious metals remain in focus. Unresolved geopolitical conflicts also continue to drive defense machinery forward. Here, a volume in the triple-digit billion range is expected, which will result in revenue in the coming years. The train is running at full steam!
Read
Commented by André Will-Laudien on April 16th, 2025 | 07:45 CEST
Tariff madness drives gold! Caution advised with Barrick, Globex Mining, Mutares, and Steyr
Every day brings a new spectacle from the White House. What resembles a farce is, unfortunately, a harsh reality. The new president, Donald Trump, leaves no doubt about who dictates the conditions in global trade. But even Mr. Universe has to row back now and then because experts have a clever piece of advice or two on how to avoid completely running the US into the ground. After all, the proclaimed tariffs threaten a severe cooling of the global economy and a surge in inflation - a perfect opportunity for precious metal investments. Due to the general uncertainty, defense stocks also remain in focus. We do the math.
Read
Commented by André Will-Laudien on April 14th, 2025 | 08:00 CEST
Growth despite tariffs: It is all about using artificial intelligence! Novo Nordisk, NetraMark Holdings, Infineon, and Intel
The tariff policy of the Trump administration is casting a long shadow over the global economy, with ifo Institute President Clemens Fuest warning it could even trigger a new global recession. Only a handful of companies can currently afford to relax - those that manufacture entirely within the US and serve mainly domestic markets. However, the economy is highly interconnected, the recently favored globalization has ensured that. The wheel is currently turning backwards, and "local sourcing" is the new buzzword. History has shown that protectionism rarely leads to positive outcomes. It is important for investors to look closely at which policymakers truly have an understanding of economic issues without ideological distortions. Identifying these trends can lead to discovering high-potential stocks. The search is not easy, but we are here to provide support wherever possible.
Read
Commented by André Will-Laudien on April 11th, 2025 | 07:15 CEST
Trump rally boosts Vidac Pharma: Further milestones in cancer research achieved!
Humanity continues to fight relentlessly against cancer. As one of the most common causes of death, researchers have been trying to unravel the secrets of this terrible disease for more than 175 years. Meanwhile, early detection and forms of therapy have come a long way, and many patients diagnosed with cancer often go on to live for many years after their diagnosis. However, it is still too early for triumph; progress is incremental and costs time and money. The dream of biotech investors is to find the needle in the haystack. Which publicly listed company will achieve the long-awaited breakthrough? Vidac Pharma has so far achieved recognized milestones and continues its research in a targeted manner. According to a recent study on the Company, investors could see a tenfold increase over the next few years. This is reason enough for us to take a closer look!
Read
Commented by André Will-Laudien on April 10th, 2025 | 07:20 CEST
Tariffs, rare earths, Greenland, and Trump! BYD, European Lithium, VW, and thyssenkrupp in focus
The cat is out of the bag! Donald Trump is imposing tariffs of 20 to 34%, thus snubbing his transatlantic trade partners. What has worked well for years is now being put to the test. It did not take long for reactions to the extensive tariff plans to materialize. The state and party leadership in Beijing responded to Trump's ultimatum by announcing counter-tariffs of 34 to 84%. This means that the escalation spiral in the trade dispute between the USA and China continues. The EU had already imposed some additional tariffs in March and is now waiting to see whether the US administration will change its mind. Meanwhile, the focus is once again on rare earths, as China is now imposing export restrictions on this precious commodity. Trump's imperialism is also targeting Greenland again. This is an interesting situation for investors.
Read
Commented by André Will-Laudien on April 10th, 2025 | 07:00 CEST
The tariff crash à la Trump is on! dynaCERT is causing a stir at the world's largest construction machinery trade fair
Traffic in Munich is currently at a standstill for a week. With the start of the largest trade fair for construction machinery, building material machines, mining machines, construction vehicles, and construction equipment, "bauma" in Munich is taking a future-oriented look at innovations across many sectors of the economy. With over 600,000 square meters of exhibition space and more than 3,500 exhibitors, it offers a platform for cross-border exchange. More than 500,000 visitors are expected. Even though the stock markets are currently correcting, climate change issues remain high on the agenda. Companies that can deliver productive approaches in this area remain the focus of sustainably-minded investors. The Canadian innovator dynaCERT (WKN: A1KBAV | ISIN: CA26780A1084 | TSE: DYA) can deliver significant savings in energy consumption with its combustion optimization via hydrogen and provides its customers with access to the coveted CO2 certificates. The international rollout is already in full swing. Trump's tariff madness and the current stock market correction offer a sustainable opportunity for investors.
Read
Commented by André Will-Laudien on April 7th, 2025 | 07:00 CEST
Trump tariff crash – Now is the time to pick the cherries! Steyr, Mutares, naoo AG, Deutsche Bank, and Commerzbank in focus
Donald J. Trump is making the world tremble. After he read out his list of punitive tariffs of 10 to 34% in the middle of the week, the international stock markets went into free fall. The DAX, DOW, and NASDAQ corrected by over 10% and closed at a daily low on Friday. The reason: China had imposed immediate countermeasures of 34%. A nightmare for consumers worldwide. Because on top of the inflation that has already manifested itself since Corona, there is now a further surge in prices that cannot be absorbed by anything. However, it will be costly for the Americans - they import over 70% of their goods abroad. The winners could be China and Europe if a free trade agreement is now agreed and the US is simply left out in the cold. Where are the opportunities for investors?
Read
Commented by André Will-Laudien on April 2nd, 2025 | 09:05 CEST
Tesla is out; SMRs are in! Green hydrogen in focus at nucera, Nel ASA, Plug Power, First Hydrogen, and Oklo
Even if Donald Trump denies climate change, the international community still has hydrogen and alternative energies on the agenda. Within the new US administration, nuclear projects have been under discussion for several months, alongside an emphasis on fossil fuels. Small modular reactors (SMRs) are being discussed in this context. They can be planned and put into operation in a much shorter time and are highly flexible in their applications. In the US, Oklo is moving forward in this area, and the Canadian company First Hydrogen is also in the starting blocks to roll out its innovative solutions. This means that green hydrogen remains in focus. Which stocks are coming to the fore?
Read
Commented by André Will-Laudien on April 1st, 2025 | 07:20 CEST
Was that the Trump crash? Nevertheless, steeply upwards with Evotec, Bayer, BioNTech, Defence Therapeutics, or Valneva?
Since November 2024, Donald Trump has driven the markets sharply upward - his controversial new presidency was largely celebrated by investors. Now, his leadership feels somewhat unsettling, with fires seemingly being set again at every corner. The new president is acting more imperiously than ever, with Panama, Canada, and Greenland verbally on the agenda as the next US states. Meanwhile, the US administration is facing a considerable deficit, which is to be addressed by drastically reducing the size of the public sector and introducing tariffs. Unsurprisingly, interest rates are now rising sharply, which is a reason for weaker prices in the biotech sector. However, the sector has done its homework and is emerging from a three-year downturn. Are we now at buying levels?
Read